fda
88 records
FDA Drug Recall: GLUTATHIONE 200MG/ML (MDV) INJECTION SOLN, 30 ML per vial, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: VITAMIN B COMPLEX 100 (MDV), 30 ML per Vial, RXQ Compounding, 340 West State Str
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 3
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: TRAVASOL 10% (AMINO ACID) INJECTION SOLUTION, 50 ML per Vial, RXQ Compounding, 3
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: BUFFERED LIDOCAINE HCL 1% INJECTION SOL (PF) SYR, 0.5 ML per vial, RXQ Compoundi
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b)
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ONDANSETRON 2 MG/ML INJECTION SOLUTION (PFV), 2 ML per vial, RXQ Compounding, 34
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PYRIDOXINE (PFV) 100MG/ML, 30ML PER VIAL. RXQ Compounding, 340 West State Street
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-I
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PROCAINE HCL (PFV) 20 MG/ML INJECTABLE SOLUTION, 30 ML per vial, RXQ Compounding
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MAGNESIUM CHLORIDE HEXAHYDRATE (PFV) 20% INJ SOLN, 50 ML per vial, RXQ Compoundi
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compoundi
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: RIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe. RXQ Compounding,
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: TURBO DROPS (PHEN 2.5% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per drop
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compound
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EDETATE DISODIUM 15% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West Stat
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: METHYLCOBALAMIN 10MG/ML INJECTABLE SOLUTION (MDV), 10 ML per vial, RXQ Compoundi
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MAGNESIUM CHLORIDE HEXAHYDRATE (MDV) 20% INJ SOLN, 50 ML per vial, RXQ Compoundi
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EDETATE DISODIUM 30% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West Stat
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: SUCCINYLCHOLINE CHLORIDE 20MG/ML INJ SOL, 10 ML per Vial, RXQ Compounding, 340 W
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ZINC SULFATE 1MG/ML INJECTION SOLUTION, 30ML per VIAL, RXQ Compounding, 340 West
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: CALCIUM GLUCONATE 5% INJECTION SOLUTION (MDV), 20 ML per vial, RXQ Compounding,
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PHO-TID-CHOL 50MG/ DEOXYCHOLIC 42 MG/ML INJ, 30 ML per vial, RXQ Compounding, 34
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: SOD-PHOS (PHOS 3MMOL/ML-SOD 4MEQ/ML) PFV INJ SOLN, 10 ML PER VIAL, RXQ Compound
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compoun
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: LIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 W
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: TURBO DROPS (PHEN 10% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropp
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: HYDROXOCOBALAMIN 1000 MCG/ML (MDV), 30 ML per vial, RXQ Compounding, 340 West St
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC:
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: TURBO CAINE 2.5 (PHEN2.5/CYCLO1/ TROP1/TETRA 0.5), 0.4 ML per Syringe, RXQ Compo
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compoundin
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DEXTROSE 50% INJECTION SOLUTION (PF) VIAL, 50 ML per vial, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: fentaNYL 0.05MG/ML INJ SOL (PF), 55ML per syringe (C-II) RXQ Compounding, 340 We
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MOXIFLOXACIN 0.5% OPHTH SOLUTION SYRINGE, 1 ML per syringe, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ZINC SULFATE 1MG/ML INJECTION SOLUTION (PFV), 10ML per VIAL, RXQ Compounding, 34
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DEXPANTHENOL 250MG/ML (MDV) INJECTION SOLN, 30ML per vial, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: TURBO DROPS (PHEN 0.625%/CYCLO 0.25%/TROP 0.25%/KETO 0.125%) OPHTH SOLN, 0.4 ML
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: CALCIUM CHLORIDE 100MG/ML (PFV) INJ SOLN, 10 ML per vial, RXQ Compounding, 340 W
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EPHEDRINE 5MG/ML (PF) SYRINGE, 5 ML per syringe, RXQ Compounding, 340 West State
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EPINEPHrine 4MG ADDED TO D5W 5%, 250 ML per bag, RXQ Compounding, 340 West State
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-019
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: HYDROGEN PEROXIDE 3% INJECTABLE PFV, 30 ML per vial, RXQ Compounding, 340 West S
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MOLYBDENUM 0.025MG/ML INJECTION SOLUTION, 10ML per vial, RXQ Compounding, 340 We
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: TAURINE 50 MG/ML (MDV) INJECTABLE, 30 ML per Vial, RXQ Compounding, 340 West Sta
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: THIAMINE HCL 100MG/ML (MDV) INJECTION, 10 ML per Vial, RXQ Compounding, 340 West
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PROCAINE HCL 8% (PFV) INJECTABLE, 10ML PER VIAL, RXQ Compounding, 340 West State
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: METHYLCOBALAMIN (PFV) 10 MG/ML INJECTABLE, 10 ML per vial, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: HYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West St
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Edetate Disodium150mg/mL PFV, 10 ML per Vial, RXQ Compounding, 340 West State St
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: BUFFERED LIDOCAINE HCL 1% INJECTION SOLUTION (PF), 10ML per vial, RXQ Compoundin
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Uni
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compou
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: VITAMIN B COMPLEX 100 (PFV), [2 or 30 ML] per Vial, RXQ Compounding, 340 West St
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: FOLIC ACID 5MG/ML INJECTION SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC: 70731-0137-03 and 30ML N
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PREDNISOLONE 1%, MOXIFLOXACIN 0.5% OPHTH SOL, 5ML per dropper bottle, RXQ Compou
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MIC (METHIONINE/INOSITOL/CHOLINE CHLORIDE) 25/50/50 MG/ML INJ, 30 ML per vial, R
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EDETATE DISODIUM 15% INJECTABLE, 30 ML per vial, RXQ Compounding, 340 West State
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: POTASSIUM CHLORIDE 15% (2MEQ/ML) INJ SOLN, 30 ML per vial, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PROCAINE HCL 20 MG/ML (MDV) INJECTABLE SOLUTION, 30 ML per vial. RXQ Compoundin
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Ascorbic Acid 500 MG/ML (Non-Corn) INJ (MDV), 50 mL per vial, RXQ Compounding, 3
2019-08-14
Class II — Crystallization
View Source
FDA Drug Recall: STERILE WATER FOR INJECTION USP, [10, 30, or 50 ML] per Vial, RXQ Compounding, 3
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Ascorbic Acid 400 MG/ML (Non-Corn) Injection Solution, 65 mL per vial, RXQ Compo
2019-08-14
Class II — Crystallization
View Source
FDA Drug Recall: DIMERCAPTO-PROPANESULFONIC 5% (DMPS)( (PFV) INJ SOL, 5 ML per vial, RXQ Compound
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: LIDOCAINE HCL 1% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 W
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: KETAMINE 50 MG/ML (NPV) INJECTION SOLUTION (C-III), 10 ML per vial, RXQ Compound
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF), 1 ML PER VIAL, RXQ Compounding,
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: METHYLCOBALAMIN 1 MG/ML (MDV) INJECTABLE SOLUTION, 10 ML per vial, RXQ Compoundi
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: LIDOCAINE 0.75%/Epinephrine 0.025%/BSS 0.56ML SYR, 1 ML PER Syringe, RXQ Compoun
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding,
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Inositol/Choline B12:B6, 50/50/1/0.175 MG/ML INJ SOLN(Sulfa Free Lipostat), 30 M
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SOL SYR (C-IV), 10 ML per syringe, RXQ Compoun
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Copper 0.4MG/ML (PVF) INJECTION SOLUTION, 10 ML per vial, RXQ Compounding, 340 W
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ROPIVICAINE 0.2%, INJ SOLN, 550 ML ON-Q PUMP. RXQ Compounding, 340 West State St
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compound
2019-08-14
Class II — Crystallization
View Source
FDA Drug Recall: MAGNESIUM 200 MG/ML/ CALCIUM GLUC 6MG/ML/ ZINC 1MG/ML, 5ML per vial, RXQ Compoun
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: CYANCOBALAMIN 1200MCG/ML MDV INJECTION, 30 ML per vial, RXQ Compounding, 340 Wes
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compoundin
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 34
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NEOSTIGMINE METHYL SULFATE 1MG/ML INJ SOL SYR, 5 ML per syringe, RXQ Compounding
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE, 100 ML per vial, RXQ Compounding,
2019-08-14
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx onl
2018-10-31
Class II — Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
View Source
FDA Drug Recall: methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compo
2017-10-25
Class II — Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
View Source
ny_corps
1 records
NY Corp: RXQ COMPOUNDING, LLC
2016-08-26
FOREIGN LIMITED LIABILITY COMPANY | County: Albany | Jurisdiction: Ohio
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.